what are the potential side effects of glp-1 drugs long-term cancer Overdose risks increase as demand for injectable weight-loss on rise, research finds GLP-1 Medications Infographic | Medidex
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 62.Weaving G, Batstone GF, Jones RG
10.1136/bmj.m4573
Key Players In The Global GLP-1 Receptor Agonist Market Major companies operating in the glp-1 receptor agonist market are Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbH, Hanmi Pharm Co
Int J Mol Sci 2020, 21(4)
Common side effects may include nausea, vomiting, diarrhea or constipation, particularly when doses are increased
Gastrointestinal events were the most common adverse events in both groups and generally occurred during dose escalation
